BlackRock’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.42M Buy
2,388,453
+1,222,069
+105% +$2.77M ﹤0.01% 3672
2025
Q1
$742K Sell
1,166,384
-73,394
-6% -$46.7K ﹤0.01% 4232
2024
Q4
$1.28M Buy
1,239,778
+71,212
+6% +$73.3K ﹤0.01% 4114
2024
Q3
$1.38M Buy
1,168,566
+29,537
+3% +$34.9K ﹤0.01% 4049
2024
Q2
$1.39M Buy
1,139,029
+7,821
+0.7% +$9.54K ﹤0.01% 4028
2024
Q1
$2.47M Sell
1,131,208
-4,927
-0.4% -$10.7K ﹤0.01% 3878
2023
Q4
$1.76M Sell
1,136,135
-3,501
-0.3% -$5.43K ﹤0.01% 4012
2023
Q3
$1.47M Sell
1,139,636
-8,180
-0.7% -$10.6K ﹤0.01% 4044
2023
Q2
$1.97M Buy
1,147,816
+24,044
+2% +$41.4K ﹤0.01% 3975
2023
Q1
$1.7M Sell
1,123,772
-176,229
-14% -$266K ﹤0.01% 4043
2022
Q4
$2.08M Sell
1,300,001
-499,362
-28% -$799K ﹤0.01% 4037
2022
Q3
$2.61M Sell
1,799,363
-27,228
-1% -$39.5K ﹤0.01% 3974
2022
Q2
$3.34M Sell
1,826,591
-3,165,503
-63% -$5.79M ﹤0.01% 3917
2022
Q1
$13.3M Buy
4,992,094
+29,732
+0.6% +$79.4K ﹤0.01% 3348
2021
Q4
$21.5M Sell
4,962,362
-90,239
-2% -$391K ﹤0.01% 3175
2021
Q3
$25.7M Sell
5,052,601
-28,022
-0.6% -$143K ﹤0.01% 3065
2021
Q2
$32.2M Sell
5,080,623
-108,082
-2% -$684K ﹤0.01% 2959
2021
Q1
$40.1M Buy
5,188,705
+1,383,526
+36% +$10.7M ﹤0.01% 2727
2020
Q4
$24.9M Sell
3,805,179
-301,548
-7% -$1.98M ﹤0.01% 2832
2020
Q3
$27.3M Sell
4,106,727
-30,582
-0.7% -$203K ﹤0.01% 2623
2020
Q2
$34.5M Buy
4,137,309
+196,531
+5% +$1.64M ﹤0.01% 2438
2020
Q1
$30.2M Sell
3,940,778
-75,270
-2% -$577K ﹤0.01% 2354
2019
Q4
$33.4M Sell
4,016,048
-1,535
-0% -$12.8K ﹤0.01% 2565
2019
Q3
$29.6M Buy
4,017,583
+127,534
+3% +$941K ﹤0.01% 2567
2019
Q2
$43.6M Buy
3,890,049
+25,658
+0.7% +$288K ﹤0.01% 2375
2019
Q1
$41.5M Buy
3,864,391
+3,463
+0.1% +$37.2K ﹤0.01% 2366
2018
Q4
$58.3M Sell
3,860,928
-7,638
-0.2% -$115K ﹤0.01% 2144
2018
Q3
$71.6M Buy
3,868,566
+642,165
+20% +$11.9M ﹤0.01% 2175
2018
Q2
$73.8M Buy
3,226,401
+716,096
+29% +$16.4M ﹤0.01% 2117
2018
Q1
$71.4M Sell
2,510,305
-136,294
-5% -$3.88M ﹤0.01% 2045
2017
Q4
$55.9M Buy
2,646,599
+586,698
+28% +$12.4M ﹤0.01% 2206
2017
Q3
$37.4M Buy
2,059,901
+247,389
+14% +$4.5M ﹤0.01% 2436
2017
Q2
$28.1M Buy
1,812,512
+800,528
+79% +$12.4M ﹤0.01% 2561
2017
Q1
$17.5M Buy
1,011,984
+1,002,351
+10,405% +$17.3M ﹤0.01% 2811
2016
Q4
$106K Buy
9,633
+289
+3% +$3.18K ﹤0.01% 2450
2016
Q3
$146K Buy
9,344
+1,759
+23% +$27.5K ﹤0.01% 2317
2016
Q2
$77K Buy
7,585
+7,479
+7,056% +$75.9K ﹤0.01% 2657
2016
Q1
$1K Buy
+106
New +$1K ﹤0.01% 3461